Abstract:
Formulations and methods of making solar cells are disclosed. In general, the invention presents a solar cell contact made from a mixture wherein the mixture comprises a solids portion and an organics portion, wherein the solids portion comprises from about 85 to about 99 wt % of a metal component, and from about 1 to about 15 wt % of a lead-free glass component. Both front contacts and back contacts are disclosed.
Abstract:
Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle. In other embodiments, the method includes the introduction of structurally reinforcing agents. In other embodiments, agents are introduced into a ventricle to increase compliance of the ventricle. In an alternative embodiment, the prevention of remodeling includes the prevention of thinning of the ventricular infarct zone. In another embodiment, the prevention of remodeling and thinning of the infarct zone involves the cross-linking of collagen and prevention of collagen slipping. In other embodiments, the structurally reinforcing agent may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.
Abstract:
A mask for masking a stent during a coating procedure may include a mask body that has a negative pattern or an approximate negative pattern of a stent pattern being masked by the mask body. An apparatus for selectively coating a predetermined portion of a medical article may include a dispenser of a coating composition, a mask, a device for creating a relative movement between the mask and the medical article.
Abstract:
Methods of coating a stent subsequent to mounting or crimping of the stent on a balloon of a catheter assembly are disclosed. One method includes forming a sacrificial layer on a balloon of a catheter assembly; followed by mounting a stent on the balloon, the stent including struts separated by gaps; followed by forming a stent coating on the stent; and followed by removal of the sacrificial layer. Another method includes mounting a stent on a balloon, the stent including struts separated by gaps; followed by forming a sacrificial layer on the balloon in the areas of the gaps between struts of the stent; followed by forming a coating on the stent; and followed by removing the sacrificial layer, wherein the coating remains on an outer surface of the stent.
Abstract:
Methods are disclosed for controlling the morphology and the release-rate of active agent from coating layers for medical devices comprising a polymer matrix and one or more active agents. The methods comprise fixing the morphology or phase distribution of the active agent prior to removing solvent from the coating composition. The coating layers can be used for controlled the delivery of an active agent or a combination of active agents.
Abstract:
A delivery catheter that includes a flexible shaft having a proximal end and a distal end, the distal end having an outer diameter less than about 13 mm; a delivery lumen having a proximal end and a distal end, the delivery lumen within the flexible shaft, the delivery lumen having at least an outlet port or at least one side hole at the distal end of the delivery lumen, the delivery lumen having a cross-sectional area at least about 5 mm2; a pressure monitoring lumen having a proximal end and a distal end, the pressure monitoring lumen within the flexible shaft; a pressure port adjacent to and connected to the distal end of the pressure monitoring lumen; a balloon inflation lumen having a proximal end and a distal end, the balloon inflation lumen within the flexible shaft; a soft tip at the distal end of the flexible shaft; a balloon at the distal end of the flexible shaft, the balloon connected to the distal end of the balloon inflation lumen, the balloon includes at least one of the following materials, polyether block amide resin, polyetheramide, polyurethane, silicone, natural latex, or synthetic latex; wherein the balloon is adapted to inflate to a diameter range of about 4 to about 15 mm.
Abstract:
An expandable medical device or component thereof including a tubular body formed of a wrapped sheet of porous polymeric material fused together, the tubular body having a fused seam at an angle relative to the longitudinal axis of the tubular body which changes along the length of the tubular body from a first angle to a second angle greater than the first angle. The sheet of porous polymeric material is wound and then fused together such that the winding angle is less in a first longitudinal section of the tubular body compared with the winding angle in a second longitudinal section of the tubular body, in order to provide the second section with greater resistance to expansion (i.e., lower compliance) than the first section.
Abstract:
A method of making a catheter balloon or other expandable medical device, and a balloon or other device formed thereby, in which at least a portion of a tubular, wrapped sheet of polymeric material is heated with laser radiation to form a fused seam extending along at least a section of the length of the tubular body. In one embodiment, the portion of the sheet heated by laser radiation is less than the entire area of the sheet, so that the fused seam is formed by heating portions of the sheet without heating sections of the sheet spaced apart from the fused seam. In one embodiment, the sheet of polymeric material comprises a polymer having a porous and preferably a node and fibril microstructure, which in one embodiment is selected from the group consisting of expanded polytetrafluoroethylene (ePTFE) and expanded ultra high molecular weight polyethylene.
Abstract:
The present invention provides partially crystallizing lead-free and cadmium-free glass enamel composition that fuse at low temperatures. Glass enamel compositions according to the present invention form predominantly bismuth titanate and optionally zinc titanate crystals upon firing. Preferably, glass enamel compositions according to the invention include a glass component that includes by weight from about 11% to about 52% SiO2, from 10.2% to about 40% TiO2, from about 5% to about 75% Bi2O3, up to about 8% B2O3, up to about 14% BaO+SrO, and up to about 45% by weight ZnO, where the sum of Bi2O3 and ZnO comprises from about 30% to about 85% of the glass component by weight.
Abstract translation:本发明提供在低温下熔化的部分结晶的无铅和无镉玻璃搪瓷组合物。 根据本发明的玻璃搪瓷组合物在烧制时主要形成钛酸铋和钛酸锌晶体。 优选地,根据本发明的玻璃搪瓷组合物包括玻璃组分,其重量含量为约11%至约52%SiO 2,10.2%至约40%TiO 2 / >,约5%至约75%的Bi 2 O 3,至多约8%的B 2 O 3 3 / ,高达约14%的BaO + SrO和至多约45重量%的ZnO,其中Bi 2 O 3 N 3和ZnO的总和包含约30重量% %至约85%的玻璃组分。